Vironika, LLC, is an early stage drug discovery company dedicated to developing novel drugs to block deadly tumor viruses from forming cancers.  Unlike any other existing treatments, Vironika’s technology platform include small molecule inhibitors that target viral proteins which will eliminate tumor viruses in their latent hidden and lytic forms. In addition, Vironika utilizes unique viral components to develop novel gene therapy approaches.